loadpatents
name:-0.053071975708008
name:-0.035446882247925
name:-0.012089967727661
Lancaster; Thomas M. Patent Filings

Lancaster; Thomas M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lancaster; Thomas M..The latest application filed is for "ultra-long acting insulin-fc fusion protein".

Company Profile
12.44.53
  • Lancaster; Thomas M. - Wenham MA
  • Lancaster; Thomas M. - Stoneham MA
  • Lancaster, Thomas M. - Somerville MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Insulin-Fc fusions and methods of use
Grant 11,359,001 - Lancaster , et al. June 14, 2
2022-06-14
Ultra-long acting insulin-Fc fusion proteins
Grant 11,352,407 - Lancaster , et al. June 7, 2
2022-06-07
Ultra-long Acting Insulin-fc Fusion Protein
App 20220098266 - Zion; Todd C. ;   et al.
2022-03-31
Antigen Specific Immunotherapy For Covid-19 Fusion Proteins And Methods Of Use
App 20220088182 - Zion; Todd C. ;   et al.
2022-03-24
Ultra-long acting insulin-Fc fusion proteins and methods of use
Grant 11,267,862 - Lancaster , et al. March 8, 2
2022-03-08
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20220064251 - Lancaster; Thomas M. ;   et al.
2022-03-03
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20220064250 - Lancaster; Thomas M. ;   et al.
2022-03-03
Ultra-long Acting Insulin-fc Fusion Protein And Methods Of Use
App 20220056098 - Lancaster; Thomas M. ;   et al.
2022-02-24
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20220017590 - Lancaster; Thomas M. ;   et al.
2022-01-20
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20220009990 - Lancaster; Thomas M. ;   et al.
2022-01-13
Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use
Grant 11,213,581 - Zion , et al. January 4, 2
2022-01-04
Ultra-long acting insulin-Fc fusion protein and methods of use
Grant 11,198,719 - Zion , et al. December 14, 2
2021-12-14
Ultra-long acting insulin-Fc fusion protein and methods of use
Grant 11,192,930 - Lancaster , et al. December 7, 2
2021-12-07
Ultra-long acting insulin-Fc fusion proteins and methods of use
Grant 11,186,623 - Lancaster , et al. November 30, 2
2021-11-30
Antigen Specific Immunotherapy For Covid-19 Fusion Proteins And Methods Of Use
App 20210346490 - Zion; Todd C. ;   et al.
2021-11-11
Ultra-long Acting Insulin-fc Fusion Protein And Methods Of Use
App 20210340212 - Zion; Todd C. ;   et al.
2021-11-04
Ultra-long Acting Insulin-fc Fusion Protein And Methods Of Use
App 20210324033 - Lancaster; Thomas M. ;   et al.
2021-10-21
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20210309709 - Lancaster; Thomas M. ;   et al.
2021-10-07
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20210300983 - Lancaster; Thomas M. ;   et al.
2021-09-30
Conjugate Based Systems For Controlled Insulin Delivery
App 20210177981 - Yan; Lin ;   et al.
2021-06-17
Ultra-long acting insulin-Fc fusion proteins and methods of use
Grant 10,961,294 - Lancaster , et al. March 30, 2
2021-03-30
Ultra-long acting insulin-Fc fusion proteins and methods of use
Grant 10,947,292 - Lancaster , et al. March 16, 2
2021-03-16
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20200407413 - LANCASTER; THOMAS M. ;   et al.
2020-12-31
Ultra-long acting insulin-FC fusion proteins and methods of use
Grant 10,870,686 - Lancaster , et al. December 22, 2
2020-12-22
Ultra-long acting insulin-Fc fusion proteins and methods of use
Grant 10,851,147 - Lancaster , et al. December 1, 2
2020-12-01
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20200231646 - Lancaster; Thomas M. ;   et al.
2020-07-23
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20200157170 - Lancaster; Thomas M. ;   et al.
2020-05-21
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20200157171 - Lancaster; Thomas M. ;   et al.
2020-05-21
Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Use
App 20200157169 - Lancaster; Thomas M. ;   et al.
2020-05-21
Insulin-fc Fusions And Methods Of Use
App 20200131243 - Lancaster; Thomas M. ;   et al.
2020-04-30
Insulin-Fc fusions and methods of use
Grant 10,597,435 - Lancaster , et al.
2020-03-24
Insulin-fc Fusions And Methods Of Use
App 20190315828 - Lancaster; Thomas M. ;   et al.
2019-10-17
Conjugate based systems for controlled drug delivery
Grant 10,398,781 - Zion , et al. Sep
2019-09-03
Conjugate Based Systems For Controlled Drug Delivery
App 20180064824 - Zion; Todd C. ;   et al.
2018-03-08
Binding-site modified lectins and uses thereof
Grant 9,745,355 - Zion , et al. August 29, 2
2017-08-29
Conjugate based systems for controlled drug delivery
Grant 9,579,391 - Zion , et al. February 28, 2
2017-02-28
Crystalline Insulin-conjugates
App 20170022262 - Lancaster; Thomas M. ;   et al.
2017-01-26
Crystalline insulin-conjugates
Grant 9,463,249 - Lancaster , et al. October 11, 2
2016-10-11
Conjugate Based Systems For Controlled Drug Delivery
App 20160193351 - Zion; Todd C. ;   et al.
2016-07-07
Conjugate based systems for controlled drug delivery
Grant 9,265,838 - Zion , et al. February 23, 2
2016-02-23
Conjugate Based Systems For Controlled Drug Delivery
App 20150265717 - Zion; Todd C. ;   et al.
2015-09-24
Exogenously triggered controlled release materials and uses thereof
Grant 9,114,176 - Zion , et al. August 25, 2
2015-08-25
Terminally-functionalized conjugates and uses thereof
Grant 9,095,623 - Zion , et al. August 4, 2
2015-08-04
Recombinantly expressed insulin polypeptides and uses thereof
Grant 9,074,015 - Lancaster , et al. July 7, 2
2015-07-07
Recombinant lectins, binding-site modified lectins and uses thereof
Grant 9,068,013 - Lancaster , et al. June 30, 2
2015-06-30
Conjugate based systems for controlled drug delivery
Grant 9,050,370 - Zion , et al. June 9, 2
2015-06-09
Synthetic conjugates and uses thereof
Grant 8,940,690 - Zion , et al. January 27, 2
2015-01-27
Drug-ligand conjugates, synthesis thereof, and intermediates thereto
Grant 8,933,207 - Chen , et al. January 13, 2
2015-01-13
Crystalline insulin-conjugates
Grant 8,906,850 - Zion , et al. December 9, 2
2014-12-09
Binding-site Modified Lectins And Uses Thereof
App 20140342980 - Zion; Todd C. ;   et al.
2014-11-20
Exogenously triggered controlled release materials and uses thereof
Grant 8,846,103 - Zion , et al. September 30, 2
2014-09-30
Conjugate Based Systems For Controlled Drug Delivery
App 20140274888 - Zion; Todd C. ;   et al.
2014-09-18
Crystalline Insulin-conjugates
App 20140275476 - Lancaster; Thomas M. ;   et al.
2014-09-18
Exogenously Triggered Controlled Release Materials And Uses Thereof
App 20140256622 - Zion; Todd C. ;   et al.
2014-09-11
Methods for reducing the mitogenicity of lectin compositions
Grant 8,729,242 - Lancaster , et al. May 20, 2
2014-05-20
Terminally Functionalized Conjugates And Uses Thereof
App 20140121159 - Zion; Todd C. ;   et al.
2014-05-01
Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the local concentration of an indicator
Grant 8,697,643 - Lancaster , et al. April 15, 2
2014-04-15
Soluble Non-depot Insulin Conjugates And Uses Thereof
App 20140037699 - Zion; Todd C. ;   et al.
2014-02-06
Terminally-functionalized conjugates and uses thereof
Grant 8,623,345 - Zion , et al. January 7, 2
2014-01-07
Polynucleotide aptamer-based cross-linked materials and uses thereof
Grant 8,603,529 - Zion , et al. December 10, 2
2013-12-10
Recombinant Lectins, Binding-site Modified Lectins And Uses Thereof
App 20130324702 - Lancaster; Thomas M. ;   et al.
2013-12-05
Uses Of Macrophage Mannose Receptor To Screen Compounds And Uses Of These Compounds
App 20130302825 - Murikipudi; Sylaja ;   et al.
2013-11-14
Soluble non-depot insulin conjugates and uses thereof
Grant 8,569,231 - Zion , et al. October 29, 2
2013-10-29
Drug-ligand Conjugates, Synthesis Thereof, And Intermediates Thereto
App 20130190475 - Chen; Zhiyu ;   et al.
2013-07-25
Recombinantly Expressed Insulin Polypeptides And Uses Thereof
App 20130190476 - Lancaster; Thomas M. ;   et al.
2013-07-25
Drug-ligand Conjugates, Synthesis Thereof, And Intermediates Thereto
App 20130131310 - Kane; John ;   et al.
2013-05-23
Polymer-drug Conjugates
App 20120135919 - Lancaster; Thomas M. ;   et al.
2012-05-31
Exogenously Triggered Controlled Release Materials And Uses Thereof
App 20120046223 - Zion; Todd C. ;   et al.
2012-02-23
Terminally-functionalized Conjugates And Uses Thereof
App 20120014908 - Zion; Todd C. ;   et al.
2012-01-19
Soluble Non-depot Insulin Conjugates And Uses Thereof
App 20120010134 - Zion; Todd C. ;   et al.
2012-01-12
Conjugate Based Systems For Controlled Drug Delivery
App 20110301083 - Zion; Todd C. ;   et al.
2011-12-08
Polynucleotide Aptamer-based Cross-linked Materials And Uses Thereof
App 20110281939 - Zion; Todd C. ;   et al.
2011-11-17
Crystalline Insulin-conjugates
App 20110281791 - Zion; Todd C. ;   et al.
2011-11-17
Binding-site Modified Lectins And Uses Thereof
App 20110281792 - Zion; Todd C. ;   et al.
2011-11-17
Synthetic Conjugates And Uses Thereof
App 20110275560 - Zion; Todd C. ;   et al.
2011-11-10
Methods For Reducing The Mitogenicity Of Lectin Compositions
App 20100130726 - LANCASTER; Thomas M. ;   et al.
2010-05-27
Methods for reducing the mitogenicity of lectin compositions
Grant 7,687,608 - Lancaster , et al. March 30, 2
2010-03-30
Methods for reducing the mitogenicity of lectin compositions
App 20070110811 - Lancaster; Thomas M. ;   et al.
2007-05-17
Polymer-drug conjugates
App 20070099820 - Lancaster; Thomas M. ;   et al.
2007-05-03
Porous carbon structures and methods
App 20050214539 - Ying, Jackie Y. ;   et al.
2005-09-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed